Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing... Read more.
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
SAN DIEGO–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics... Read more.
Kwello Launches ElsieAI ™ : Revolutionizing Conversational Data Analysis for Medical Affairs Teams
Innovative solution combines the power of AI technology with user-friendly interface to unlock valuable insights effortlessly. ROANOKE, Va.–(BUSINESS WIRE)–Kwello,... Read more.
Mega Trucking and Prime Insurance Company Partner to Fight and Win Frivolous Litigation
SALT LAKE CITY–(BUSINESS WIRE)–#Claims–Rick J. Lindsey, President and CEO of Prime Insurance Company, a specialty insurance carrier, announced... Read more.
OFS Credit Company Announces Financial Results for the First Fiscal Quarter 2024
CHICAGO–(BUSINESS WIRE)–OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit,” the “Company,” “we,” “us” or “our”), an investment... Read more.
Global Surgical Robot Market Insights & Forecasts Report 2024-2028 with Focus on the United States and China – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Surgical Robot Market (By Type & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)”... Read more.
United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence – Forecasts to 2028 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact... Read more.
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy
– Preclinical data show ARO-DM1 reduces muscular DMPK expression and corrects spliceopathies, which could lead to improved muscle strength and function PASADENA,... Read more.
VSE Corporation Declares Quarterly Cash Dividend
ALEXANDRIA, Va.–(BUSINESS WIRE)–VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair... Read more.
APi Group Announces Participation in the 2024 J.P. Morgan Industrials Conference
NEW BRIGHTON, Minn.–(BUSINESS WIRE)–APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that its senior leadership will... Read more.